The Food and Drug Administration advisory panel voted Tuesday to endorse “kid-size” doses of Pfizer’s COVID-19 vaccination for children, ages 5-to 11-year-olds. The Associated Press reports the panel “voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks. That includes questions about a heart-related side effect that’s been very rare in teen and young adults despite their use of a much higher vaccine dose.”
However, this summer, a researcher at Johns Hopkins found a mortality rate of zero among children who did not have a pre-existing medical condition such as Leukemia. Marty Makary wrote an Op-Ed in the Wall Street Journal titled, “The Flimsy Evidence Behind the CDC’s Push to Vaccinate Children” which cautions against forcing a COVID-19 vaccine on children. Regarding the coronavirus, “a tremendous number of government and private policies affecting kids are based on one number: 335” writes Makary.
The number 335 is “how many children under 18 have died with a Covid diagnosis code in their record, according to the Centers for Disease Control and Prevention” explains Makary. “Yet the CDC, which has 21,000 employees, hasn’t researched each death to find out whether Covid caused it or if it involved a pre-existing medical condition.”
“My research team at Johns Hopkins worked with the nonprofit FAIR Health to analyze approximately 48,000 children under 18 diagnosed with Covid in health-insurance data from April to August 2020” Makary went on. “Our report found a mortality rate of zero among children without a pre-existing medical condition such as leukemia.”
“Without these data, the CDC Advisory Committee on Immunization Practices decided in May that the benefits of two-dose vaccination outweigh the risks for all kids 12 to 15” writes Makary, who states “I’ve written hundreds of peer-reviewed medical studies, and I can think of no journal editor who would accept the claim that 335 deaths resulted from a virus without data to indicate if the virus was incidental or causal, and without an analysis of relevant risk factors such as obesity.”
The Associated Press reports the FDA “isn’t bound by the panel’s recommendation and is expected to make its own decision within days.” If the FDA agrees with the panel, “there’s still another step: Next week, the CDC will have to decide whether to recommend the shots and which youngsters should get them.”